More specifically, in patients with cystic fibrosis, SNPs that profoundly affect IDO2 expression and/or function did not associate with an increased risk of aspergillosis, whereas the same SNPs were required for optimal antifungal activity in patients who have undergone hematopoietic stem cell transplantation (23). This evidence concerns the gene IDO2 and aspergillosis.